Dermapharm Holding SE (DMPHF)
48.60
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Dermapharm EPS Diluted (Quarterly) : 0.7975 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bayer AG | -1.113 |
| Merck KGaA | 0.1708 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 42.08M |
| Revenue (Quarterly) | 343.98M |
| Total Expenses (Quarterly) | 301.05M |
| Enterprise Value | 3.609B |
| Gross Profit Margin (Quarterly) | 33.55% |
| Profit Margin (Quarterly) | 12.23% |
| Earnings Yield | 5.73% |
| Operating Earnings Yield | 9.82% |
| Normalized Earnings Yield | 5.938 |